Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-label Study of Escitalopram in the Treatment of Major Depressive Disorder in Elderly Patients With Alzheimer's Disease

NCT00488670 is registered in ClinicalTrials.gov with University of British Columbia as lead sponsor.

NCT NCT00488670
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00488670 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-label Study of Escitalopram in the Treatment of Major Depressive Disorder in Elderly Patients With Alzheimer's Disease
Lead sponsor
University of British Columbia
Phase
Phase 3
Overall status
Terminated
Start date
December 31, 2010
Completion date
June 30, 2011
Enrollment
50 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

depressive disorder